Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 171Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf

FDA
22 Feb 2023

https://www.globenewswire.com/news-release/2022/07/19/2481807/0/en/SCYNEXIS-Presents-Positive-Data-from-Phase-3-CANDLE-Nested-Sub-Study-Investigating-Ibrexafungerp-in-Women-with-Recurrent-Yeast-Infections-Who-Failed-Fluconazole-During-the-ISSVD-XX.html

GLOBENEWSWIRE
19 Jul 2022

https://www.healio.com/news/womens-health-ob-gyn/20211001/oteseconazole-proves-safe-effective-against-recurrent-vulvovaginal-candidiasis

FIRSTWORDPHARMA
04 Oct 2021

https://www.businesswire.com/news/home/20210812005217/en

BUSINESSWIRE
12 Aug 2021

https://www.prnewswire.com/news-releases/ani-pharmaceuticals-announces-acquisition-of-fluconazole-tablets-301088173.html#:~:text=ANI%20Pharmaceuticals%2C%20Inc.&text=(%22ANI%22)%20(Nasdaq,according%20to%20IQVIA%2FIMS%20Health.

PRNEWSWIRE
06 Jul 2020

http://portal.anvisa.gov.br/noticias/-/asset_publisher/FXrpx9qY7FbU/content/anvisa-aprova-vacina-influenza-para-idosos/219201?p_p_auth=kATyHONb&inheritRedirect=false&redirect=http%3A%2F%2Fportal.anvisa.gov.br%2Fnoticias%3Fp_p_auth%3DkATyHONb%26p_p_id%3D101_INSTANCE_FXrpx9qY7FbU%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3D_118_INSTANCE_veHKmkDUo2dN__column-2%26p_p_col_count%3D2

ANVISA
16 Oct 2018